← Back to Search

Proof-of-concept trial for Brain Metastases (AIM 2 Trial)

N/A
Waitlist Available
Led By Ashlee R Loughan, PhD
Research Sponsored by Virginia Commonwealth University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3 months
Awards & highlights
No Placebo-Only Group

Summary

This trial aims to evaluate and adapt CALM therapy for caregivers of patients with neurological cancers. The goal is to provide better emotional support through counseling sessions that help manage stress and improve well-being. CALM therapy is a brief individual psychotherapy designed to help patients with advanced cancer cope with emotional distress and promote psychological well-being.

Eligible Conditions
  • Cancer Brain Metastases
  • Caregiver
  • Neuro-Oncology

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 3 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Evaluate suitability of the CALM intervention to the needs of caregivers in neuro-oncology by measuring caregiver satisfaction.
Evaluate suitability of the CALM intervention to the needs of caregivers in neuro-oncology by measuring caregivers' recommendations to the content and format of the intervention during an exit-interview.

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: Proof-of-concept trialExperimental Treatment1 Intervention
Inform CALM adaptations for caregivers of patients with brain cancer.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
CALM Therapy
2021
N/A
~20

Find a Location

Who is running the clinical trial?

Virginia Commonwealth UniversityLead Sponsor
716 Previous Clinical Trials
22,888,497 Total Patients Enrolled
American Psychological FoundationOTHER
18 Previous Clinical Trials
1,972 Total Patients Enrolled
Ashlee R Loughan, PhDPrincipal InvestigatorVirginia Commonwealth University
~0 spots leftby Nov 2025